Splenic infarction and bevacizumab

David Malka; Marc Van Den Eynde; Valérie Boige; Clarisse Dromain; Michel Ducreux

doi:10.1016/s1470-2045(06)70980-9

Splenic infarction and bevacizumab

David Malka, Marc Van Den Eynde, Valérie Boige, Clarisse Dromain, Michel Ducreux

Institut Gustave Roussy

Research output: Contribution to journal › Comment/debate

8 Scopus citations

Original language	English
Pages (from-to)	1038
Number of pages	1
Journal	The Lancet Oncology
Volume	7
Issue number	12
DOIs	https://doi.org/10.1016/s1470-2045(06)70980-9
State	Published - Dec 2006
Externally published	Yes

Access to Document

10.1016/s1470-2045(06)70980-9

Cite this

@article{951ea0f8faff416d870b5c736a47f74a,

title = "Splenic infarction and bevacizumab",

author = "David Malka and {Van Den Eynde}, Marc and Val{\'e}rie Boige and Clarisse Dromain and Michel Ducreux",

year = "2006",

month = dec,

doi = "10.1016/s1470-2045(06)70980-9",

language = "אנגלית",

volume = "7",

pages = "1038",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - Splenic infarction and bevacizumab

AU - Malka, David

AU - Van Den Eynde, Marc

AU - Boige, Valérie

AU - Dromain, Clarisse

AU - Ducreux, Michel

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33751316745&partnerID=8YFLogxK

U2 - 10.1016/s1470-2045(06)70980-9

DO - 10.1016/s1470-2045(06)70980-9

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 17138227

AN - SCOPUS:33751316745

SN - 1470-2045

VL - 7

SP - 1038

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 12

ER -

Splenic infarction and bevacizumab

Access to Document

Other files and links

Cite this